Table #3. Outcome Data Before and After Protocol.
| 9/2009-9/2011 No Transfusion (n=87) | 9/2009-9/2011 Received Transfusion (n=39) | After 9/2011 No Transfusion (n=46) | After 9/2011 Received Transfusion (n=14) | P-Values | |
|---|---|---|---|---|---|
| Complication | 35.1% (31) | 61.8% (24) | 4.5% (2) | 80% (11) | 0.000*,0.012‡, 0.001†,0.024δ |
| Intraoperative Surgical Complication | |||||
| None | 98.9% (86) | 94.9% (37) | 97.8% (45) | 85.7% (12) | |
| Hemorrhage | 1.1% (1) | 2.6% (1) | 0.0% | 7.1% (1) | |
| Hypotensive Episode | 0.0% | 2.6% (1) | 2.2% (1) | 7.1% (1) | |
| Grade of Complication | |||||
| Oral Antibiotics | 24.1% (7) | 4.2% (1) | 20.0% (1) | 0.0% | |
| IV Antibiotics | 55.2% (16) | 33.3% (8) | 20.0% (1) | 20.0% (1) | |
| Return to ICU Percutaneous Drainage Operative Correction | 20.7% (6) | 58.3% (14) | 40.0% (2) | 60.0% (3) | |
| Organ Diversion | 0.0% | 0.0% | 0.0% | 0.0% | |
| Death | 0.0% | 4.2% (1) | 20.0% (1) | 20.0% (1) | |
| Infection | 0.0% | 2.6% (1) | 0.0% | 7.1% (1) | |
| Length of Stay | 5.0 | 8.0 | 5.0 | 8.0 | 0.009δ |
| New Recurrence | 23.0% (20) | 12.8% (5) | 9.3% (4) | 21.4% (3) | |
| Site of Recurrence | |||||
| Liver | 56.5% (26) | 69.2% (9) | 25.0% (2) | 50.0% (1) | |
| Lung | 19.6% (9) | 0.0% | 12.5% (1) | 0.0% | |
| Bone | 6.5% (3) | 0.0% | 12.5% (1) | 0.0% | |
| Lymph Nodes | 6.5% (3) | 7.7% (1) | 0.0% | 50.0% (1) | |
| Other | 10.9% (5) | 23.1% (3) | 50.0% (4) | 0.0% | |
| Karnofsky Score | 100 | 90 | 100 | 100 | |
| Status | |||||
| No Evidence of Disease | 48.3% (42) | 41.0% (16) | 60.5% (26) | 57.1% (8) | |
| Alive with Disease | 42.5% (37) | 38.5% (15) | 34.9% (15) | 28.6% (4) | |
| Died of Disease | 8.0% (7) | 7.7% (3) | 2.3% (1) | 0.0% | |
| Died of Other Cause | 1.1% (1) | 12.8% (5) | 2.3% (1) | 14.3% (2) | 0.002*,0.01 1‡, |
*
all patients that received blood compared to all patients that did not receive blood
†
patients after the protocol that received blood compared to patients after the protocol that did not receive blood
‡
patients before the protocol that received blood compared to patients before the protocol that did not receive blood
δ
patients before the protocol that received blood compared to patients after the protocol that received blood